In the latest market close, Abbott (ABT) reached $113.70, with a -0.39% movement compared to the previous day. This move lagged the S&P 500's daily loss of 0.19%. Meanwhile, the Dow experienced a rise ...

This was the stock's third consecutive day of losses.

The Nifty Pharma index closed on a positive note on Friday. Shares of Mankind Pharma Ltd.(up 4.53 per cent), Torrent ...

Piper Sandler initiates coverage on Abbott with an Overweight rating, citing its diversified business model, strong medtech ...

Abbott Laboratories (ABT) stock saw a decline, ending the day at $114.88 which represents a decrease of $-3.25 or -2.75% from the prior close of $118.13. The stock opened at $117.5 and touched a low ...

Fintel reports that on September 19, 2024, Piper Sandler initiated coverage of Abbott Laboratories ( NYSE:ABT) with a Overweight recommendation.

Abbott ABT is facing a challenging business environment globally. Unfavorable foreign exchange impact continues to impede ...

DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

Adam Maeder, an analyst from Piper Sandler, has initiated a new Buy rating on Abbott Laboratories (ABT). Adam Maeder has given his Buy rating ...

We recently compiled a list of the Jim Cramer’s Top 10 Stock Picks You Can’t Ignore. In this article, we are going to take a ...

The stock's fall snapped a two-day winning streak.

Plans for two new nickel trading platforms to challenge the London Metal Exchange (LME) have been blown off course by BHP's ...